{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:59:42Z","timestamp":1790477982555,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.coph.2017.12.003","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T01:26:59Z","timestamp":1515720419000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["The cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities"],"prefix":"10.1016","volume":"40","author":[{"given":"Mitsuhiro","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2017.12.003_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","article-title":"Cholinergic modulation of the immune system presents new approaches for treating inflammation","volume":"179","author":"Hoover","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2017.12.003_bib0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nn.4477","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2017.12.003_bib0320","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20120571","article-title":"Neural reflexes in inflammation and immunity","volume":"209","author":"Andersson","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2017.12.003_bib0325","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-immunol-020711-075015","article-title":"Reflex principles of immunological homeostasis","volume":"30","author":"Andersson","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0330","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1113\/JP271539","article-title":"Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation","volume":"594","author":"Bonaz","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2017.12.003_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-015-0239-2","article-title":"Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons","volume":"12","author":"Santoni","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.coph.2017.12.003_bib0340","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions: facts and hypotheses","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2017.12.003_bib0345","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbi.2007.03.008","article-title":"Autonomic innervation and regulation of the immune system (1987\u20132007)","volume":"21","author":"Nance","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2017.12.003_bib0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3940(94)11105-R","article-title":"Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication","volume":"183","author":"Watkins","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coph.2017.12.003_sbref0355","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_sbref0360","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_bib0365","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20052362","article-title":"Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis","volume":"203","author":"Huston","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2017.12.003_bib0370","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.181.5.3535","article-title":"Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels","volume":"181","author":"Huston","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0375","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0803237105","article-title":"Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia","volume":"105","author":"Rosas-Ballina","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.12.003_bib0380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-1838(93)90046-W","article-title":"Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia","volume":"42","author":"Berthoud","year":"1993","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.coph.2017.12.003_bib0385","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0889-1591(89)90029-9","article-title":"Origin of noradrenergic innervation of the spleen in rats","volume":"3","author":"Bellinger","year":"1989","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2017.12.003_sbref0390","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1209985","article-title":"Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit","volume":"334","author":"Rosas-Ballina","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coph.2017.12.003_sbref0395","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1096\/fj.11-191007","article-title":"beta2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system","volume":"25","author":"Vida","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2017.12.003_bib0400","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrgastro.2017.85","article-title":"Neurogastroenterology: the dynamic cycle of life in the enteric nervous system","volume":"14","author":"Rao","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.12.003_bib0405","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","article-title":"The enteric nervous system and neurogastroenterology","volume":"9","author":"Furness","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2017.12.003_bib0410","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00441-016-2559-7","article-title":"The nervous system of airways and its remodeling in inflammatory lung diseases","volume":"367","author":"Audrit","year":"2017","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.coph.2017.12.003_bib0415","series-title":"The Toxicant Induction of Irritant Asthma, Rhinitis, and Related Conditions","first-page":"19","article-title":"Airway anatomy, physiology, and inflammation","author":"Van Scott","year":"2013"},{"key":"10.1016\/j.coph.2017.12.003_bib0420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autneu.2007.01.008","article-title":"Parasympathetic control of airway submucosal glands: central reflexes and the airway intrinsic nervous system","volume":"133","author":"Wine","year":"2007","journal-title":"Auton Neurosci: Basic Clin"},{"key":"10.1016\/j.coph.2017.12.003_bib0425","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2006.11.005","article-title":"Airway nociceptors activated by pro-inflammatory cytokines","volume":"156","author":"Yu","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.coph.2017.12.003_bib0430","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.4049\/jimmunol.168.10.5297","article-title":"Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction","volume":"168","author":"van Houwelingen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0435","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/jir.2008.0076","article-title":"IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells","volume":"29","author":"Saperstein","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.coph.2017.12.003_bib0440","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1165\/rcmb.2006-0240OC","article-title":"Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats","volume":"37","author":"Su","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2017.12.003_bib0445","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.0901808","article-title":"Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury","volume":"184","author":"Su","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0450","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/rccm.201002-0314OC","article-title":"Neuroimmune regulation of ventilator-induced lung injury","volume":"183","author":"dos Santos","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2017.12.003_bib0455","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1096\/fj.201600431R","article-title":"Acute lung injury is reduced by the alpha7nAChR agonist PNU-282987 through changes in the macrophage profile","volume":"31","author":"Pinheiro","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.coph.2017.12.003_bib0460","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.00103408","article-title":"Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia","volume":"33","author":"Giebelen","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2017.12.003_bib0465","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","article-title":"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system","volume":"47","author":"Dani","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.coph.2017.12.003_bib0470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.coph.2017.12.003_bib0475","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(24)36503-6","article-title":"Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function","volume":"280","author":"Albuquerque","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2017.12.003_bib0480","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1152\/jn.1995.74.3.1212","article-title":"Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits","volume":"74","author":"Mandelzys","year":"1995","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.coph.2017.12.003_bib0485","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(96)12889-5","article-title":"An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype","volume":"213","author":"Papke","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coph.2017.12.003_bib0490","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1523\/JNEUROSCI.2444-07.2007","article-title":"Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1\/2 and CREB phosphorylation pathways","volume":"27","author":"Bitner","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2017.12.003_bib0495","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bmcl.2003.09.104","article-title":"Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes","volume":"14","author":"Papke","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coph.2017.12.003_bib0500","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/jm0602413","article-title":"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure\u2013activity relationship","volume":"49","author":"Wishka","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2017.12.003_bib0505","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/jpet.104.076968","article-title":"The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats","volume":"312","author":"Hajos","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2017.12.003_bib0510","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clinthera.2014.09.013","article-title":"Pharmacodynamics, pharmacokinetics, safety, and tolerability of encenicline, a selective alpha7 nicotinic receptor partial agonist, in single ascending-dose and bioavailability studies","volume":"37","author":"Barbier","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.coph.2017.12.003_bib0515","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0091-3057(96)00354-1","article-title":"Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo","volume":"57","author":"Briggs","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.coph.2017.12.003_bib0520","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1073\/pnas.98.4.2089","article-title":"Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning","volume":"98","author":"Woodruff-Pak","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.12.003_bib0525","doi-asserted-by":"crossref","first-page":"14686","DOI":"10.1073\/pnas.0804372105","article-title":"Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"105","author":"Young","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.12.003_bib0530","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1523\/JNEUROSCI.5269-04.2005","article-title":"A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization","volume":"25","author":"Hurst","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2017.12.003_bib0535","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1073\/pnas.1017975108","article-title":"Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"108","author":"Gill","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2017.12.003_bib0540","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1021\/jm9003818","article-title":"Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor","volume":"52","author":"Faghih","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2017.12.003_bib0545","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/jpet.109.151886","article-title":"In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile","volume":"330","author":"Malysz","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2017.12.003_bib0550","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.4049\/jimmunol.180.11.7655","article-title":"Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens","volume":"180","author":"Mishra","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0555","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.0902227","article-title":"Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7\/alpha 9\/alpha 10-nicotinic receptors","volume":"185","author":"Mishra","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0560","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_bib0565","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ni.3094","article-title":"Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets","volume":"16","author":"Robinette","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0570","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2017.12.003_bib0575","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coph.2017.12.003_sbref0580","doi-asserted-by":"crossref","first-page":"13202","DOI":"10.1038\/ncomms13202","article-title":"Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity","volume":"7","author":"Galle-Treger","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2017.12.003_sbref0585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_sbref0590","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_sbref0595","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coph.2017.12.003_bib0600","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fimmu.2017.01085","article-title":"Expression and function of the cholinergic system in immune cells","volume":"8","author":"Fujii","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2017.12.003_bib0605","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.201609-1794CI","article-title":"How do dual long-acting bronchodilators prevent exacerbations of chronic obstructive pulmonary disease?","volume":"196","author":"Beeh","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2017.12.003_bib0610","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12931-016-0386-8","article-title":"Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells","volume":"17","author":"Cazzola","year":"2016","journal-title":"Respir Res"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921730200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921730200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T20:07:30Z","timestamp":1751227650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148921730200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":61,"alternative-id":["S147148921730200X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2017.12.003","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cholinergic anti-inflammatory pathway: an innovative treatment strategy for respiratory diseases and their comorbidities","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}